Abstract:Angewandte ChemieVolume 124, Issue 27 p. 6846-6851 Zuschrift Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System† Yuanzeng Min, Yuanzeng Min CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorCheng-Qiong Mao, Cheng-Qiong Mao CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)Search for more papers by this authorSiming Chen, Siming Chen CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorGuolin Ma, Guolin Ma CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorProf. Jun Wang, Corresponding Author Prof. Jun Wang jwang699@ustc.edu.cn CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China) Jun Wang, CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)=== Yangzhong Liu, CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)===Search for more papers by this authorProf. Yangzhong Liu, Corresponding Author Prof. Yangzhong Liu liuyz@ustc.edu.cn CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China) Jun Wang, CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)=== Yangzhong Liu, CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)===Search for more papers by this author Yuanzeng Min, Yuanzeng Min CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorCheng-Qiong Mao, Cheng-Qiong Mao CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)Search for more papers by this authorSiming Chen, Siming Chen CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorGuolin Ma, Guolin Ma CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)Search for more papers by this authorProf. Jun Wang, Corresponding Author Prof. Jun Wang jwang699@ustc.edu.cn CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China) Jun Wang, CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)=== Yangzhong Liu, CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)===Search for more papers by this authorProf. Yangzhong Liu, Corresponding Author Prof. Yangzhong Liu liuyz@ustc.edu.cn CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China) Jun Wang, CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027 (China)=== Yangzhong Liu, CAS Key Laboratory of Soft Matter Chemistry and Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026 (China)===Search for more papers by this author First published: 25 May 2012 https://doi.org/10.1002/ange.201201562Citations: 31 † This work was supported by the National Basic Research Program of China (973 Program, 2012CB932502, 2010CB934001, and 2009CB918804), the National Science Foundation of China (21171156 and 51125012) and the Fundamental Research Funds for the Central Universities. Read the full textAboutPDF ToolsRequest permissionAdd to favorites ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Graphical Abstract Widerstand ist zwecklos: Ein Platin(IV)-Prodrug, das an ein Wirkstofftransportsystem auf der Basis von Goldnanostäbchen konjugiert ist, vermeidet die Art von Wirkstoffresistenz, die mit Cisplatin assoziiert ist (siehe Bild). Das Konjugat wird durch Endocytose in Zellen aufgenommen und umgeht dadurch die resistenzassoziierte Aufnahme, die durch das Kupfertransportprotein Ctr1 vermittelt wird. Das Platin(IV)-Prodrug ist gegen deaktivierendes Glutathion und Metallothionein inerter als Cisplatin. Citing Literature Supporting Information Detailed facts of importance to specialist readers are published as "Supporting Information". Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description ange_201201562_sm_miscellaneous_information.pdf1.1 MB miscellaneous_information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume124, Issue27July 2, 2012Pages 6846-6851 This is the German version of Angewandte Chemie. Note for articles published since 1962: Do not cite this version alone. Take me to the International Edition version with citable page numbers, DOI, and citation export. We apologize for the inconvenience. RelatedInformation

The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation.

Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).

Interaction Between Platinum Complexes And The C-Terminal Motif Of Human Copper Transporter 1

Reduced 64cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1

Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma

Identification Of Binding Sites Of Cisplatin To Human Copper Chaperone Protein Cox17 By High-Resolution Ft-Icr-Ms

Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis

Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop

[Structure-functional organization of eukaryotic high-affinity copper importer CTR1 determines its ability to transport copper, silver and cisplatin]

The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.

Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking

Ammonium Tetrathiomolybdate Treatment Targets the Copper Transporter Atp7a and Enhances Sensitivity of Breast Cancer to Cisplatin

Cisplatin induces drug resistance in human esophageal squamous carcinoma cells by reducing CTR1 expression

Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1.

Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics

Correlation of Expression of Human Copper Transporter 1 with Cisplatin Resistance in Ovarian Carcinoma

Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation (adv. Healthcare Mater. 26/2023)

Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System